Global Mesalazine Market Trends 2022 | Segmentation, Outlook, Industry Report to 2028

Mesalazine, also known as mesalamine or 5-aminosalicylic acid, is a drug used to treat inflammatory bowel diseases, including ulcerative colitis and crohn’s disease. It is generally used with mild to moderate severe diseases. It is brought into the mouth or rectum.Mesalamine belongs to a class of drugs called anti-inflammatory drugs that help to control and prevent ulcerative colitis by blocking the production of inflammatory chemicals in the intestines called prostaglandins to reduce inflammation.

Scope of the Report

The research study analyzes the global Mesalazine industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

Market Segmentation:

By Company

• PharmaZell
• Syntese A/S
• Cambrex Corporation
• Divis Laboratories
• Chemi SpA
• Ipca Laboratories
• Hangzhou Brother
• Lianyungang Fengheng Biopharm

By Type

• Purity 鈮97%
• Purity 鈮98%
• Purity 鈮99%

By Application

• Tablets
• Capsules
• Pellet and Granule
• Suppository
• Enema
• Others

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

Key Questions Answered by Mesalazine Market Report

1. What was the Mesalazine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Mesalazine Market during the forecast period (2022-2028)?

3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).

4. Which manufacturer/vendor/players in the Mesalazine Market was the market leader in 2020?

5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.